Veracyte director plans sale of 5,000 shares

Rhea-AI Filing Summary

VERACYTE, INC. (VCYT) director Jens Hendrik Holstein filed a Rule 144 notice indicating an intention to sell 5,000 shares of Veracyte common stock through Morgan Stanley Smith Barney LLC. The shares have an aggregate market value of $204,747 and are listed on NASDAQ. The 5,000 shares come from restricted stock awards dated June 13, 2025 (595 shares) and June 9, 2024 (4,405 shares).

Key Figures

Shares proposed for sale: 5,000 shares Aggregate market value: $204,747 Restricted stock grant (2025): 595 shares +2 more

5 metrics

Shares proposed for sale 5,000 shares Common stock of Veracyte, Inc. covered by the Form 144 notice

Aggregate market value $204,747 Total value for 5,000 Veracyte common shares in the Form 144

Restricted stock grant (2025) 595 shares Restricted stock dated June 13, 2025, identified as a source of shares

Restricted stock grant (2024) 4,405 shares Restricted stock dated June 9, 2024, identified as a source of shares

Signature date September 14, 2026 Date associated with the Form 144 signature block

Key Terms

Rule 144, Restricted Stock, Form 144, Issuer

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock financial

"Common | 06/13/2025 | Restricted Stock | ISSUER"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Issuer regulatory

"Restricted Stock | ISSUER"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for VERACYTE, INC. (VCYT)?

The filing reports that director Jens Hendrik Holstein intends to sell 5,000 shares of Veracyte common stock under Rule 144, with an indicated aggregate market value of $204,747 through Morgan Stanley Smith Barney LLC.

How many VCYT shares are covered by Jens Holstein’s Form 144?

The notice covers 5,000 shares of Veracyte common stock. These shares are tied to restricted stock awards dated June 13, 2025 for 595 shares and June 9, 2024 for 4,405 shares.

What is the approximate value of the Veracyte (VCYT) shares in this Form 144?

The Form 144 lists an aggregate market value of approximately $204,747 for the 5,000 shares of Veracyte common stock proposed for sale on NASDAQ.

Who is the person selling Veracyte (VCYT) shares under this Form 144?

The person is Jens Hendrik Holstein, identified as a Director of Veracyte, Inc. The notice relates to the planned sale of 5,000 shares of Veracyte common stock for his account.

Through which broker will the VCYT shares in this Form 144 be sold?

The Form 144 identifies Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, as the broker for the planned sale of 5,000 Veracyte common shares on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 05:02 PM Accepted by SEC EDGAR 09/14/2026 - 05:00 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001819880
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERACYTE, INC.
SEC File Number	001-36156
Address of Issuer	6000 Shoreline Court Suite 300, South San Francisco CALIFORNIA 94080
Phone	(650) 243-6300
Name of Person for Whose Account the Securities are To Be Sold	JENS HOLSTEIN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	204747.00	80390731	09/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/13/2025	Restricted Stock	ISSUER			595	06/13/2025	Not Applicable
Common	06/09/2024	Restricted Stock	ISSUER			4405	06/09/2024	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jens Hendrik Holstein
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)